Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bowness

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|October 1, 1994
Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27P Bowness, R L Allen, A J McMichael
Clinical and Experimental Immunology|September 13, 2017
Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's diseaseM Giza, D Koftori, L Chen, et al.
Immunology Today|May 29, 2000
Jekyll and Hyde: the transformation of HLA-B27J C Edwards, P Bowness, J R Archer
British Journal of Rheumatology|October 1, 1991
Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritisP Bowness, K Shotliff, A Middlemiss, et al.
BMJ (Clinical Research Ed.)|February 5, 2000
Lesson of the week: difficulties in diagnosing acute rheumatic fever-arthritis may be short lived and carditis silentL Williamson, P Bowness, A Mowat, et al.
Tissue Antigens|April 4, 2002
The quantity of naturally processed peptides stably bound by HLA-A*0201 is significantly reduced in the absence of tapasinL D Barber, M Howarth, P Bowness, et al.
Expert Reviews in Molecular Medicine|October 31, 2003
HLA-B27 and disease pathogenesis: new structural and functional insightsP Bowness, N Zaccai, L Bird, et al.
British Journal of Anaesthesia|July 1, 1988
Hepatotoxicity after general anaesthesiaG R Foster, P Bowness, K Holder, et al.
Scandinavian Journal of Rheumatology|August 13, 2005
Neck pain is a major clinical problem in ankylosing spondylitis, and impacts on driving and safetyW Holden, S Taylor, H Stevens, et al.
Arthritis and Rheumatism|October 29, 2005
Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritisA T Chan, S D Kollnberger, L R Wedderburn, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|October 1, 1994
Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27P Bowness, R L Allen, A J McMichael
Clinical and Experimental Immunology|September 13, 2017
Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's diseaseM Giza, D Koftori, L Chen, et al.
Immunology Today|May 29, 2000
Jekyll and Hyde: the transformation of HLA-B27J C Edwards, P Bowness, J R Archer
British Journal of Rheumatology|October 1, 1991
Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritisP Bowness, K Shotliff, A Middlemiss, et al.
BMJ (Clinical Research Ed.)|February 5, 2000
Lesson of the week: difficulties in diagnosing acute rheumatic fever-arthritis may be short lived and carditis silentL Williamson, P Bowness, A Mowat, et al.
Tissue Antigens|April 4, 2002
The quantity of naturally processed peptides stably bound by HLA-A*0201 is significantly reduced in the absence of tapasinL D Barber, M Howarth, P Bowness, et al.
Expert Reviews in Molecular Medicine|October 31, 2003
HLA-B27 and disease pathogenesis: new structural and functional insightsP Bowness, N Zaccai, L Bird, et al.
British Journal of Anaesthesia|July 1, 1988
Hepatotoxicity after general anaesthesiaG R Foster, P Bowness, K Holder, et al.
Scandinavian Journal of Rheumatology|August 13, 2005
Neck pain is a major clinical problem in ankylosing spondylitis, and impacts on driving and safetyW Holden, S Taylor, H Stevens, et al.
Arthritis and Rheumatism|October 29, 2005
Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritisA T Chan, S D Kollnberger, L R Wedderburn, et al.
Pageof 4